• Je něco špatně v tomto záznamu ?

Serum adiponectin level in obstructive sleep apnea: Relation of adiponectin to obesity and long-term continuous positive airway pressure therapy

M. Hobzová, R. Salzman, D. Stejskal, J. Zapletalová, V. Kolek,

. 2016 ; 61 (1) : 130-4. [pub] 20151104

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, pozorovací studie, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc17014194

PURPOSE: The study aimed to determine the effect of OSA and obesity on the plasma levels of adiponectin and the long-term effect of CPAP on its plasma levels and obesity parameters. MATERIAL/METHODS: A prospective observational study included 159 newly diagnosed OSA patients. The cohort was divided into CPAP treated (n=82) and control group (n=77). Both groups were examined at the beginning and a year later. The CPAP-treated patients were additionally tested after a month of therapy. The examinations included Epworth Sleepiness Scale questionnaire, anthropometric and polysomnographic measurements, and blood serum tests. Changes in the studied parameters of OSA, obesity, and adiponectin obtained at the beginning and after follow-up period were compared in each group. RESULTS: In CPAP group, all studied OSA parameters improved already after a month of CPAP therapy. Contrarily, obesity parameters (except of neck and waist circumference) remained unchanged after CPAP therapy. Serum adiponectin levels dropped during CPAP therapy. In the control group, both obesity and OSA parameters did not show changes. The only exceptions were deteriorated mean SpO2 and decreased hip circumference. Adiponectin remained unchanged in this group. In neither group, the Spearman correlation analyses showed any association of serum adiponectin levels with obesity or OSA parameters, except of mean SpO2. CONCLUSIONS: Only correlation found was between adiponectin and mean SpO2. Although CPAP therapy improves all OSA parameters, it did not change most obesity parameters. Additionally in the CPAP group, there was a significant drop in adiponectin levels, suggesting its protective role in this group of patients.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17014194
003      
CZ-PrNML
005      
20170428094238.0
007      
ta
008      
170413s2016 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.advms.2015.10.004 $2 doi
035    __
$a (PubMed)26674570
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Hobzová, Milada $u Department of Respiratory Medicine, University Hospital and Palacky University Olomouc, Olomouc, Czech Republic. Electronic address: milada.hobzova@seznam.cz.
245    10
$a Serum adiponectin level in obstructive sleep apnea: Relation of adiponectin to obesity and long-term continuous positive airway pressure therapy / $c M. Hobzová, R. Salzman, D. Stejskal, J. Zapletalová, V. Kolek,
520    9_
$a PURPOSE: The study aimed to determine the effect of OSA and obesity on the plasma levels of adiponectin and the long-term effect of CPAP on its plasma levels and obesity parameters. MATERIAL/METHODS: A prospective observational study included 159 newly diagnosed OSA patients. The cohort was divided into CPAP treated (n=82) and control group (n=77). Both groups were examined at the beginning and a year later. The CPAP-treated patients were additionally tested after a month of therapy. The examinations included Epworth Sleepiness Scale questionnaire, anthropometric and polysomnographic measurements, and blood serum tests. Changes in the studied parameters of OSA, obesity, and adiponectin obtained at the beginning and after follow-up period were compared in each group. RESULTS: In CPAP group, all studied OSA parameters improved already after a month of CPAP therapy. Contrarily, obesity parameters (except of neck and waist circumference) remained unchanged after CPAP therapy. Serum adiponectin levels dropped during CPAP therapy. In the control group, both obesity and OSA parameters did not show changes. The only exceptions were deteriorated mean SpO2 and decreased hip circumference. Adiponectin remained unchanged in this group. In neither group, the Spearman correlation analyses showed any association of serum adiponectin levels with obesity or OSA parameters, except of mean SpO2. CONCLUSIONS: Only correlation found was between adiponectin and mean SpO2. Although CPAP therapy improves all OSA parameters, it did not change most obesity parameters. Additionally in the CPAP group, there was a significant drop in adiponectin levels, suggesting its protective role in this group of patients.
650    _2
$a adiponektin $x krev $7 D052242
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a kohortové studie $7 D015331
650    12
$a trvalý přetlak v dýchacích cestách $7 D045422
650    _2
$a demografie $7 D003710
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a obezita $x krev $x komplikace $7 D009765
650    _2
$a obstrukční spánková apnoe $x krev $x komplikace $x terapie $7 D020181
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
655    _2
$a pozorovací studie $7 D064888
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Salzman, Richard $u Department of Otorhinolaryngology, Olomouc University Hospital and Palacky University Olomouc, Olomouc, Czech Republic.
700    1_
$a Stejskal, David $u Department of Medical Chemistry and Biochemistry, Palacky University Olomouc, Olomouc, Czech Republic.
700    1_
$a Zapletalová, Jana $u Department of Medical Biophysics, Palacky University Olomouc, Olomouc, Czech Republic.
700    1_
$a Kolek, Vítězslav $u Department of Respiratory Medicine, University Hospital and Palacky University Olomouc, Olomouc, Czech Republic.
773    0_
$w MED00189495 $t Advances in medical sciences $x 1898-4002 $g Roč. 61, č. 1 (2016), s. 130-4
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26674570 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170413 $b ABA008
991    __
$a 20170428094559 $b ABA008
999    __
$a ok $b bmc $g 1200659 $s 974972
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 61 $c 1 $d 130-4 $e 20151104 $i 1898-4002 $m Advances in medical sciences $n Adv Med Sci $x MED00189495
LZP    __
$a Pubmed-20170413

Najít záznam

Citační ukazatele

Možnosti archivace